A review in the Journal of Neurochemistry delves into the potential connections between COVID-19 and Alzheimer’s disease (AD), emphasizing the neurological symptoms experienced by COVID-19 patients.
This exploration suggests that viral infections may elevate the risk of neurodegeneration, potentially contributing to the development of AD.
Age serves as the primary contributing factor to both AD and COVID-19. Interestingly, these two conditions appear to amplify each other’s effects, potentially leading to synergistic impacts on neurodegeneration.
The authors highlight the need for further research to solidify the link between microbial infections and neurodegenerative diseases.
To investigate this, they are conducting experiments involving different strains of transgenic AD mice infected with mouse coronaviruses and murine-adapted SARS-CoV-2.
These studies aim to assess how coronavirus infections influence the severity of AD neuropathology.
The review underscores the importance of exploring potential connections between COVID-19 and AD.
As our understanding of these relationships evolves, it may shed light on the mechanisms underlying neurodegeneration, ultimately leading to novel insights into the prevention and treatment of AD.
If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and this new drug may help treat Alzheimer’s disease.
For more information about brain health, please see recent studies about a new early sign of Alzheimer’s disease, and results showing this brain problem can increase risk of stroke for up to five years.
The research findings can be found in the Journal of Neurochemistry.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
